Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Dequalinium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.97 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.97 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.97 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.97 |
| ▸ | PRKCA | P17252 | 13/20 | 0.97 |
| ▸ | MEN1 | O00255 | 4/20 | 0.97 |
| ▸ | GMNN | O75496 | 4/20 | 0.97 |
| ▸ | LMNA | P02545 | 4/20 | 0.97 |
| ▸ | POLB | P06746 | 4/20 | 0.97 |
| ▸ | MAPT | P10636 | 4/20 | 0.97 |
| ▸ | APEX1 | P27695 | 4/20 | 0.97 |
| ▸ | RECQL | P46063 | 4/20 | 0.97 |
| ▸ | BLM | P54132 | 4/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 4/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.97 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.97 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.97 |
| ▸ | TP53 | P04637 | 3/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6305111 | 0.98 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL29557297 | 0.98 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL29577841 | 0.98 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL149457 | 0.98 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| SCHEMBL6299633 | 0.98 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| SCHEMBL6298118 | 0.98 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL1008339 | 0.97 | PRKCA (0.97) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL2335922 | 0.97 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL2544854 | 0.97 | MEN1 (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL34043 | 0.97 | MEN1 (1.00) | PRKCAMEN1GMNNLMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230414570-A1 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-12-28 | — | — | US | disclosed |
| US-11793790-B2 | Compositions against Candida infections | UNIVERSITEIT ANTWERPEN (BE) | 2023-10-24 | — | — | US | disclosed |
| EP-3949962-B1 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | UNIV LEUVEN KATH (BE) | 2023-09-13 | — | — | EP | disclosed |
| EP-3949962-A1 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | Katholieke Universiteit Leuven (BE) | 2022-02-09 | — | — | EP | disclosed |
| EP-3654973-B1 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | UNIV LEUVEN KATH (BE) | 2021-08-18 | — | — | EP | disclosed |
| EP-3654973-A1 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | Katholieke Universiteit Leuven (BE) | 2020-05-27 | — | — | EP | disclosed |
| US-20200138786-A1 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | UNIVERSITEIT ANTWERPEN (BE) | 2020-05-07 | — | — | US | disclosed |
| WO-2019015975-A1 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2019-01-24 | — | — | WO | disclosed |
| US-8071640-B2 | Urea oligomers, their preparation process and pharmaceutical compositions containing them | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-12-06 | — | — | US | disclosed |
| US-20100184849-A1 | UREA OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQU (FR) | 2010-07-22 | — | — | US | disclosed |
| US-7691899-B2 | Urea oligomers, the preparation method thereof and pharmaceutical composition containing same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-04-06 | — | — | US | disclosed |
| US-20050038105-A1 | Novel urea oligomers, the preparation method thereof and pharmaceutical composition containing same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-02-17 | — | — | US | disclosed |
| WO-1996023050-A1 | CLEANSING COMPOSITIONS | JEYES GROUP PLC (GB) | 1996-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184849-A1 | UREA OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | UACA, RAN, URB2 | CHRM2 2902/4885CHRM1 2581/4885ACHE 1131/4885 |
| US-20050038105-A1 | Novel urea oligomers, the preparation method thereof and pharmaceutical composition containing same | URB2, NOXO1, UACA | CHRM2 3836/4885CHRM1 3276/4885ACHE 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.